Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 6:30 PM
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
TL;DR
Seed (YC)b12 labs — AI-powered chemical synthesis Full-stack AI platform for chemical synthesis planning and lab automation.
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2025). Investors: Y Combinator. (High).
Funding
Raised $500K across 1 funding round. Latest: $500K Pre-seed (Jan 2025). Investors: Y Combinator. (High).
Hiring
2 hiring‑related row(s); role‑spam risk if mostly generic boards (High).
Product / news
3 product/news‑styled row(s); headline risk without filings (High).
Verified facts
+1 more in Recent movement below
YC-backed chemical copilot for pharma and biotech.
Weak funding evidence: mention does not include a parsed raise amount/round and may refer to non-funding context.
No open roles indexed yet.
The index price and activity score are algorithmic estimates based on observed public company-level signals. They may be incomplete, stale, or inaccurate and are not investment, legal, tax, or business advice.
Source types found
Strongest / recent news-style rows
Wed, May 20, 06:30 PM · confidence 88%high quality
About / company · Mon, May 11, 05:15 AM · confidence 90%high quality
About / company · Mon, May 11, 05:15 AM · confidence 90%high quality
Newest first · 13 event(s)
Source: Blog
Updates, insights, and technical writing from the b12 labs team.
Source: official_site
b12 labs Cloud Reactions Publications Team Blog Get Started Cloud Reactions Publications Team Blog Backed by Y Combinator AI-Powered Chemical Synthesis AI that designs, optimizes, and runs chemical reactions. Accelerating pharma R&D from years to months. Get…
Full-stack AI platform for chemical synthesis planning and lab automation.
YC-backed chemical copilot for pharma and biotech.
Selenium, Palladium, Cobalt modules for synthesis workflows.
2 row(s)
The company's own site — the authoritative description of what they sell and to whom. Marketing-controlled, so treat claims as positioning rather than verified traction.
b12 labs Cloud Reactions Publications Team Blog Get Started Cloud Reactions Publications Team Blog Backed by Y Combinator AI-Powered Chemical Synthesis AI that designs, optimizes, and runs chemical reactions. Accelerating pharma R&D from years to months. Get…
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗Full-stack AI platform for chemical synthesis planning and lab automation.
Why it matters: Primary source — the company's own positioning; best read for what they sell and to whom, not for traction claims.
Open source ↗5 row(s)
Third-party press coverage. Independent reporting corroborates company claims; repeated coverage across outlets is a momentum signal.
AI-powered chemical synthesis platform. Plan complex routes, design experiments, automate workflows, or order synthesis.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗AI-powered chemical synthesis platform. Plan complex routes, design experiments, automate workflows, or order synthesis.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗Selenium, Palladium, Cobalt modules for synthesis workflows.
Why it matters: Independent coverage — third-party corroboration of company claims; recurring coverage indicates rising visibility.
Open source ↗1 row(s)
Funding announcements and investor-database records. The strongest public signal of capitalization: round, amount, and syndicate quality when disclosed.
YC-backed chemical copilot for pharma and biotech.
Why it matters: Funding signal — Pre-Seed per this source; verify against the linked original before relying on it.
Open source ↗2 row(s)
Open roles and careers pages. Active hiring implies runway to spend and shows where the company is investing (engineering vs GTM vs ops).
AI-powered chemical synthesis platform. Plan complex routes, design experiments, automate workflows, or order synthesis.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗AI-powered chemical synthesis platform. Plan complex routes, design experiments, automate workflows, or order synthesis.
Why it matters: Hiring signal — open roles imply runway to spend and show where the company is investing.
Open source ↗3 row(s)
Company blog and newsletters. Shipping cadence and technical depth of posts hint at product velocity and team quality.
Updates, insights, and technical writing from the b12 labs team.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗AI-powered chemical synthesis platform. Plan complex routes, design experiments, automate workflows, or order synthesis.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗AI-powered chemical synthesis platform. Plan complex routes, design experiments, automate workflows, or order synthesis.
Why it matters: Company publishing — post cadence and depth hint at product velocity.
Open source ↗Sign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.